3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.70%
Negative revenue growth while M7U.DE stands at 13.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-25.63%
Negative gross profit growth while M7U.DE is at 16.03%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.73%
Negative EBIT growth while M7U.DE is at 18.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.96%
Negative operating income growth while M7U.DE is at 18.85%. Joel Greenblatt would press for urgent turnaround measures.
-51.77%
Negative net income growth while M7U.DE stands at 2.03%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-51.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-51.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
600.75%
Dividend growth of 600.75% while M7U.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
16.25%
Positive OCF growth while M7U.DE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
31.42%
Positive FCF growth while M7U.DE is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
45.23%
5Y revenue/share CAGR 1.25-1.5x M7U.DE's 38.78%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-0.75%
Negative 3Y CAGR while M7U.DE stands at 23.27%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.84%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
136.12%
5Y net income/share CAGR above 1.5x M7U.DE's 25.78%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-73.41%
Negative 3Y CAGR while M7U.DE is 22.37%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
135.13%
Below 50% of M7U.DE's 543.51%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
13.16%
Below 50% of M7U.DE's 210.99%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
28.12%
Dividend/share CAGR of 28.12% while M7U.DE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
30.40%
3Y dividend/share CAGR of 30.40% while M7U.DE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-17.87%
Inventory is declining while M7U.DE stands at 13.95%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.26%
Negative asset growth while M7U.DE invests at 15.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.75%
We have a declining book value while M7U.DE shows 16.57%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
12.92%
Debt growth far above M7U.DE's 8.55%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-20.48%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.